Aberdeen Group
CRBU icon

Aberdeen Group’s Caribou Biosciences CRBU Stock Holding History

Aberdeen Group’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.3M Sell
1,212,541
-176,364
-13% -$303K ﹤0.01% 759
2025
Q4 		$2.21M Hold
1,388,905
– – ﹤0.01% 770
2025
Q3 		$3.24M Buy
1,388,905
+491,326
+55% +$928K 0.01% 738
2025
Q2 		$1.13M Buy
897,579
+486,435
+118% +$478K ﹤0.01% 822
2025
Q1 		$375K Buy
411,144
+229,657
+127% +$298K ﹤0.01% 889
2024
Q4 		$289K Hold
181,487
– – ﹤0.01% 898
2024
Q3 		$356K Hold
181,487
– – ﹤0.01% 863
2024
Q2 		$298K Hold
181,487
– – ﹤0.01% 895
2024
Q1 		$933K Hold
181,487
– – ﹤0.01% 828
2023
Q4 		$1.04M Buy
+181,487
New +$897K ﹤0.01% 831

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return